Description

NSE notifies listing of further issued equity shares of Unihealth Hospitals Limited and Visaman Global Sales Limited on SME EMERGE segment, effective March 13, 2026.

Summary

NSE has notified the listing of further issued equity shares of Unihealth Hospitals Limited (UNIHEALTH) and Visaman Global Sales Limited (VISAMAN) on the Capital Market segment (SME EMERGE), effective March 13, 2026. Both sets of shares were allotted pursuant to conversion of warrants on a preferential basis.

Key Points

  • Unihealth Hospitals Limited (ISIN: INE0PRF01011) listed 200,000 equity shares of Rs. 10 each at an issue price of Rs. 151, allotted on January 12, 2026
  • Visaman Global Sales Limited (ISIN: INE0BHK01012) listed 666,666 equity shares of Rs. 10 each at an issue price of Rs. 60, allotted on January 29, 2026
  • Both securities are listed under Series SM on SME EMERGE with a market lot size of 1,000
  • Both securities are pari passu with existing shares
  • Lock-in restrictions apply to all allotted shares until September 30, 2027 (Unihealth) and October 5, 2027 (Visaman)

Regulatory Changes

No new regulatory changes. The circular is issued in pursuance of Regulation 3.1.1 and Regulation 2.5.5 of the National Stock Exchange (Capital Market) Trading Regulations Part A.

Compliance Requirements

  • Trading members must use designated security codes (UNIHEALTH, VISAMAN) for trading
  • Trading must be conducted in the specified lot size of 1,000 shares
  • Lock-in restrictions must be observed for the allotted shares as per Annexure A details
  • ISIN activation is subject to SEBI circulars CIR/MRD/DP/21/2012 and CIR/MRD/DP/24/2012 for dematerialized shares

Important Dates

  • March 13, 2026: Effective date for trading of both securities on NSE
  • January 12, 2026: Date of allotment for Unihealth Hospitals Limited shares
  • January 29, 2026: Date of allotment for Visaman Global Sales Limited shares
  • September 30, 2027: Lock-in expiry for all 200,000 Unihealth shares
  • October 5, 2027: Lock-in expiry for Visaman Global Sales Limited shares

Impact Assessment

This is a routine SME EMERGE listing circular with limited broader market impact. The two companies are small-cap SME entities. Unihealth adds 200,000 shares (distinctive numbers 15499953–15699952) and Visaman adds 666,666 shares (distinctive numbers 19371100–20037765). All shares are under lock-in until late 2027, so no immediate free-float increase is expected. Market participants trading in these SME securities should note the applicable lot size of 1,000 shares.

Impact Justification

Routine further issue listing for two SME EMERGE companies involving warrant conversions on preferential basis; limited broader market impact.